📰 Diagnostic Cortex News
Diagnostic Cortex News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Diagnostic Cortex. Real-time updates on events, politics, business and more.
April 5, 2024
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, today announced the pricing of its underwritten offering of 17,391,832 shares of its common stock at a price to...
March 1, 2024
Persistent, high double-digit growth in Lung Diagnostic test volume - growing 65% in FY2023 versus FY2022 - and the sixth consecutive quarter with greater than 50% year-over-year growth; Ongoing...
February 16, 2024
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the fourth quarter and year ended December 31, 2023...
May 31, 2023
Biodesix, Inc. , a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will present and host... | May 31, 2023
May 31, 2023
BOULDER, Colo.--(BUSINESS WIRE)--May 31, 2023--
December 13, 2022
The Company’s expertise focuses on profiling the patient’s immune response to their cancer with blood-based proteomic solutions, in addition to genomic insights.
September 6, 2022
BOULDER, Colo.--(BUSINESS WIRE)--$BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences:Morgan Stanley 20th Annual Gl...
June 30, 2022
June 30, 2022Solution adds proteomic analysis of blood-based biomarkers to Philips Lung Cancer Orchestrator to better assess the risk of lung nodule malignancy, enhancing decision-making for diagnosis
June 1, 2022
01.06.2022 - Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will present at the 42nd Annual William Blair Growth Stock Conference ...
May 11, 2022
11.05.2022 - Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for first quarter ended March 31, 2022 and provided a corporate update. “We are ...